The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Guardant Health Inc shares valued at $4,645 were sold by Tariq Musa on May 19 ’25. At $40.04 per share, Tariq Musa sold 116 shares. The insider’s holdings dropped to 3,479 shares worth approximately $0.13 million following the completion of this transaction.
Also, Tariq Musa purchased 116 shares, netting a total of over 4,645 in proceeds.
Before that, Talasaz AmirAli had sold 106,784 shares from its account. In a trade valued at $5,233,421, the Co-Chief Executive Officer traded Guardant Health Inc shares for $49.01 each. Upon closing the transaction, the insider’s holdings decreased to 106,784 shares, worth approximately $84.91 million.
As published in their initiating research note from Mizuho on April 10, 2025, Guardant Health Inc [GH] has been an Outperform and the price target has been revised to $55. Analysts at Barclays started covering the stock with ‘”an Overweight”‘ outlook in a report released in late January. As of June 28, 2024, Guggenheim has increased its “Neutral” rating to a “Buy” for GH.
Analyzing GH Stock Performance
During the last five days, there has been a surge of approximately 3.94%. Over the course of the year, Guardant Health Inc shares have jumped approximately 26.19%. Shares of the company reached a 52-week high of $52.92 on 05/01/25 and a 52-week low of $30.97 on 01/02/25.
Support And Resistance Levels for Guardant Health Inc (GH)
According to the 24-hour chart, there is a support level at 38.09, which, if violated, would cause prices to drop to 37.64. In the upper region, resistance lies at 38.94. The next price resistance is at 39.34. RSI (Relative Strength Index) is 40.58 on the 14-day chart, showing neutral technical sentiment.
